Vaccine development has progressed over time from traditional prophylactic uses to more complex and novel therapeutic products. Understanding the correlation between immunity and protection is one of the most difficult aspects of developing a vaccine. Vaccine development leads to advancements in antigen and adjuvant selection which contribute to the success of a vaccine candidate while ensuring appropriate safety testing.

Our team has extensive experience providing services to the vaccine industry including appropriate pre-clinical models and efficacy and safety testing methodologies. Our global network of scientific, technical, and regulatory experts provides vaccine developers with the expertise they need early in the development process to increase productivity, efficiency, and profitability while also bringing the safest and most effective vaccines to market.

NanoExpo offers the production of recombinant proteins, virus-like particles, chimeric VLPs, the encapsulation of mRNA into dedicated particles, chitosan and silica beads counted with peptides, and additional artificial proteins that fit individualized needs.